-
1 Comment
Shandong Weigao Group Medical Polymer Company Limited is currently in a long term uptrend where the price is trading 7.2% above its 200 day moving average.
From a valuation standpoint, the stock is 95.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.1.
Shandong Weigao Group Medical Polymer Company Limited's total revenue rose by 15.4% to $6B since the same quarter in the previous year.
Its net income has increased by 16.8% to $1B since the same quarter in the previous year.
Finally, its free cash flow fell by 14.4% to $518M since the same quarter in the previous year.
Based on the above factors, Shandong Weigao Group Medical Polymer Company Limited gets an overall score of 4/5.
| Exchange | HK |
|---|---|
| ISIN | CNE100000171 |
| CurrencyCode | HKD |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Beta | 0.5 |
|---|---|
| Market Cap | 26B |
| PE Ratio | 11.63 |
| Target Price | 6.7759 |
| Dividend Yield | 4.1% |
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company's medical device products include safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions; and orthopedic products comprise spine, joint, trauma, sports medicine, bone repair material, and spinal endoscope products, as well as orthopedic devices, PRP treatment consumables, and negative pressure drainage consumables. Its pharma packaging products consist of prefilled drug delivery systems, pharmaceutical packaging consumables, automatic drug delivery systems, and pre-filled syringes; interventional products include offers tumor, vascular, and nursing interventions; and blood management products comprise whole blood collection consumables and blood transfusion equipment. The company also provides finance leasing and factoring services; medical PVC granules, plastic packing bags, and carton boxes; medical polymer materials and products; injection puncture instruments; computer technical services; consulting services; and X-ray based irradiation machines. In addition, it sells electronic products. The company was founded in 1988 and is based in Weihai, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 1066.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
